| For: | Maraone A, Tarsitani L, Pinucci I, Pasquini M. Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects? World J Psychiatr 2021; 11(9): 568-580 [PMID: 34631461 DOI: 10.5498/wjp.v11.i9.568] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i9/568.htm |
| Number | Citing Articles |
| 1 |
Riccardo Gennari, Nicole Capretti, Danial Daroui, Sergio Terracina, Lorenzo Martellone, Andrea Mastrostefano, Giuseppe Greco. The Potential Use of Selective Serotonin Reuptake Inhibitor Therapy for Gambling Disorders Associated with Impulse-Control Disorders. Targets 2026; 4(2) doi: 10.3390/targets4020019
|
| 2 |
Hasan Mirzazadeh, Younes Ghaeminia, Amin Mohamad Niaei, Mohammadsadegh Kamran, Leila Razeghian Jahromi, Reza Moshfeghinia. Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial. BMC Psychiatry 2025; 25(1) doi: 10.1186/s12888-025-06856-7
|
| 3 |
Júlia Grigorini Mori Ayub, Cristina Luz Tosta, Breno Lopes Macedo, Tattyanna Fernandes Barreto, Lorena Martins Lopes, Maria Paula dos Santos Fracalossi, Roberto Andreatini, Vanessa Beijamini. S-ketamine exerts sex- and dose-dependent anti-compulsive-like effect as monotherapy or in augmentation to fluoxetine. European Journal of Pharmacology 2022; 937 doi: 10.1016/j.ejphar.2022.175382
|
| 4 |
Jacob Blaney, Sanjana Konda, Latha Ganti. Bibliometric analysis of OCD prevalence in youth populations of developing countries. Cambridge Prisms: Global Mental Health 2025; 12 doi: 10.1017/gmh.2025.12
|
| 5 |
Rakesh Sahu. Exploring Biomarkers and Contributing Factors in Obsessive-Compulsive Disorder: Hypothesis. Academic Bulletin of Mental Health 2024; 2 doi: 10.25259/ABMH_12_2024
|
| 6 |
Mohammad Ali Salehinejad, Amir-Homayun Hallajian, Miles Wischnewski, André Aleman, Marom Bikson, Daniel M. Blumberger, Jérôme Brunelin, Andre R. Brunoni, Zafiris J. Daskalakis, Stevan Nikolin, Frank Padberg, Alexander T. Sack, Michael Siniatchkin, Odile A. van den Heuvel, Zahra Vaziri, Carmelo M. Vicario, Trevor W. Robbins, Michael A. Nitsche. Transcranial electrical stimulation for the treatment of obsessive–compulsive disorder: a triple meta-analysis. Nature Mental Health 2026; 4(4) doi: 10.1038/s44220-026-00590-z
|
| 7 |
Annalisa Maraone, Alessandro Trebbastoni, Antonella Di Vita, Fabrizia D'Antonio, Carlo De Lena, Massimo Pasquini. Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial. JMIR Research Protocols 2023; 12 doi: 10.2196/39223
|
| 8 |
Behnaz Bakhshinejad, Abdolreza Sabahi, Tania Dehesh, Zarrin Sarhadynejad, Mehrnaz Mehrabani, Mahdiyeh Khazaneha, Mehrzad Mehrbani, Mitra Mehrabani. Efficacy of the herbal product of Cuscuta campestris Yunck. and Polypodium vulgare L. in patients with obsessive-compulsive disorder: A triple-blind clinical trial. Journal of Ethnopharmacology 2026; 354 doi: 10.1016/j.jep.2025.120452
|
| 9 |
OBSESSIVE COMPULSIVE DISORDER - A REVIEW OF TREATMENT METHODS. International Journal of Innovative Technologies in Social Science 2025; 3(3(47)) doi: 10.31435/ijitss.3(47).2025.3714
|
| 10 |
Sydney Raboin. Visualizing victory: the role of imagery in empowering athletes battling obsessive-compulsive disorder. Journal of Imagery Research in Sport and Physical Activity 2024; 19(s1) doi: 10.1515/jirspa-2024-0006
|
| 11 |
Ayush Pandey, Rajat Sharma, Sonali Dixit, Shashank Tripathi. The effect of adjuvant treatment in obsessive compulsive disorder patients: A systematic review and meta-analysis. Journal of Family Medicine and Primary Care 2025; 14(12) doi: 10.4103/jfmpc.jfmpc_281_25
|
| 12 |
Sam Rashkovich, Ganeev Singh, Eric Hollander. Beyond symptom reduction: targeting cognitive deficits in obsessive-compulsive disorder treatment. International Clinical Psychopharmacology 2026; 41(1) doi: 10.1097/YIC.0000000000000603
|
| 13 |
Rituparna Maiti, Archana Mishra, Anand Srinivasan, Biswa Ranjan Mishra. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis. Acta Psychiatrica Scandinavica 2023; 148(1) doi: 10.1111/acps.13568
|